Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FT.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.11.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.11.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CU.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CU.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CA.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.83ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.83NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
AY.4.2.4 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.4.2.4 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.2.4 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.2.4 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.161ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.161ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.161ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.161NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used